Siemienowicz Miranda L, Kruger Samuel J, Goh Nicole S L, Dobson Julie E, Spelman Timothy D, Fabiny Robert P J
Radiology Department, Austin Health, Melbourne, Victoria, Australia.
Respiratory and Sleep Medicine Department, Austin Health, Melbourne, Victoria, Australia.
J Med Imaging Radiat Oncol. 2015 Oct;59(5):555-63. doi: 10.1111/1754-9485.12314. Epub 2015 May 12.
The prognosis of diffuse fibrotic lung disease (DFLD) is known to be variable, but there is a paucity of literature on prognostic markers independent of precise clinical diagnosis. This study aimed to assess the mortality prediction of three high-resolution computed tomography (HRCT) scores in a heterogeneous population of patients with DFLD. A large radiologist and physician reader group was used to determine agreement among readers of varying background in applying these scores.
Institutional review board approval was obtained. Informed consent was waived for this retrospective study. Eighty HRCTs in 68 patients with DFLD (35 men, mean age 72.9 years) were evaluated retrospectively by 18 readers. Readers included thoracic and general radiologists, respiratory physicians and radiology trainees. Features scored were honeycombing, extent of disease and traction bronchiectasis. Demographics, diagnosis and pulmonary function data were collected. Patients were categorised as having either idiopathic pulmonary fibrosis, fibrosis relating to connective tissue disease, 'miscellaneous' DFLD or 'undefined', where no single entity was felt entirely or confidently to explain the pulmonary disease. Agreement was assessed using the kappa statistic. Associations with mortality were analysed using the Cox marginal model.
Agreement was better for honeycombing (kappa = 0.44) and disease extent (kappa = 0.47) than traction bronchiectasis (kappa = 0.24). Honeycombing presence (P < 0.0005) and disease extent >30% (P = 0.002) predicted increased mortality independent of clinical diagnosis. Traction bronchiectasis was non-predictive. Clinical diagnosis was not an independent predictor, but age was independently associated with mortality (P = 0.004). Pulmonary function data were only available for 43 patients, but in a limited subanalysis, the diffusion capacity of carbon monoxide was independently predictive of increased mortality (P = 0.005).
The presence of honeycombing and a greater extent of fibrotic lung disease predict increased mortality independent of clinical diagnosis. Our large, mixed-expertise reader group shows moderate interobserver agreement, comparable with agreement values for these scores in the literature.
已知弥漫性纤维化肺病(DFLD)的预后存在差异,但关于独立于精确临床诊断的预后标志物的文献较少。本研究旨在评估三种高分辨率计算机断层扫描(HRCT)评分对异质性DFLD患者群体的死亡预测情况。使用了一个由放射科医生和内科医生组成的大型读者群体来确定不同背景的读者在应用这些评分时的一致性。
获得了机构审查委员会的批准。对于这项回顾性研究,豁免了知情同意。18名读者对68例DFLD患者(35名男性,平均年龄72.9岁)的80份HRCT进行了回顾性评估。读者包括胸科和普通放射科医生、呼吸内科医生以及放射科实习生。评分的特征包括蜂窝状改变、疾病范围和牵拉性支气管扩张。收集了人口统计学、诊断和肺功能数据。患者被分类为患有特发性肺纤维化、与结缔组织病相关的纤维化、“其他”DFLD或“未明确”,其中没有单一实体能完全或确切地解释肺部疾病。使用kappa统计量评估一致性。使用Cox边际模型分析与死亡率的关联。
对于蜂窝状改变(kappa = 0.44)和疾病范围(kappa = 0.47)的一致性优于牵拉性支气管扩张(kappa = 0.24)。蜂窝状改变的存在(P < 0.0005)和疾病范围>30%(P = 0.002)可独立于临床诊断预测死亡率增加。牵拉性支气管扩张无预测价值。临床诊断不是独立的预测因素,但年龄与死亡率独立相关(P = 0.004)。仅43例患者有肺功能数据,但在有限的亚组分析中,一氧化碳弥散能力可独立预测死亡率增加(P = 0.005)。
蜂窝状改变的存在以及更大范围的纤维化肺病可独立于临床诊断预测死亡率增加。我们这个由不同专业背景的大型读者群体显示出中等程度的观察者间一致性,与文献中这些评分的一致性值相当。